Pollution gets personal! A first population-based human biomonitoring study in Austria.
Philipp Hohenblum1, Philipp Steinbichl, Wolfgang Raffesberg
1Environmental Agency Austria (Umweltbundesamt), Spittelauer Lände 5, 1090 Vienna, Austria. philipp.hohenblum@umweltbundesamt.at
International Journal of Hygiene and Environmental Health
|October 5, 2011
Summary
This human biomonitoring study in Austria found chemical body burdens comparable to other European populations. Further optimization of non-invasive sampling and participant recruitment is needed for future representative studies.
Area of Science:
- Environmental Health
- Toxicology
- Public Health
Background:
- Humans are ubiquitously exposed to numerous man-made chemicals.
- Human biomonitoring (HBM) provides crucial data on individual body burden, independent of exposure sources.
- Previous population-based HBM studies in Austria were limited.
Purpose of the Study:
- To document the extent, distribution, and determinants of human exposure to industrial chemicals in Austria.
- To assess the feasibility of conducting a representative HBM study.
- To establish baseline body burden levels for specific chemical compounds.
Main Methods:
- A cross-sectional, population-based study involving 150 volunteers (50 families) selected via stratified random sampling.
- Analysis of exposure to phthalates, trisphosphates, polybrominated diphenyl ethers (PBDEs), bisphenol A, nonylphenol, octylphenol, and methyl mercury.
- Assessment of chemical concentrations in blood and urine samples.
Main Results:
- Sixteen of 18 assessed PBDE congeners were detected in blood samples, with congeners #153 and #197 being most abundant.
- Bisphenol A was detected above the limit of quantification (LOQ) in only 4 out of 25 urine samples.
- Trisphosphate compounds were detected above the LOQ in 3% of urine samples.
- Overall body burden levels were comparable to or lower than those reported in other European countries.
Conclusions:
- The Austrian population's body burden of assessed chemicals is relatively low compared to other European nations.
- Developing a feasible protocol for representative HBM requires optimizing non-invasive sampling techniques aligned with metabolic pathways.
- Participant recruitment procedures were labor-intensive and necessitate improvement for future large-scale studies.


